Cerebral Small Vessel Diseases Clinical Trial
Official title:
Multicenter Retrospective Study of Visit-to-Visit Variability in Blood Pressure as a Predictor of Poor Cognitive Function
Hypertension in midlife is an independent risk factor of late life cognitive dysfunction or
dementia. Chronic hypertension cause vascular damage and cerebral ischemia, which ultimately
gives rise to the cognitive dysfunction or dementia.
A recent study showed that high visit-to-visit variability in clinic systolic blood pressure
(BP) was a strong independent predictor of stroke. This finding suggests that high clinic
systolic BP variability itself as well as chronic hypertension may cause vascular damage and
cerebral ischemia. Therefore, high clinic SBP variability may be also an independent risk
factor of cognitive dysfunction or dementia.
Vascular damage leads to the diminished autoregulatory capacities of cerebral arteries. The
brain with the reduced autoregulatory capacity may be more vulnerable to BP fluctuation.
Therefore, high BP variability may be more harmful in patients with damaged vessels (for
example, in patients with cerebral small vessel disease).
Previous data about BP variability and cognition revealed very controversial. Some studies
showed poor cognition in patients with high BP variability, but others did not.
The previous studies were mostly based on cross-sectional designs, and performed in
small-sized heterogeneous population for primary prevention. The harmful effect of high BP
variability may be clearer in the population with damaged vascular bed, such as cerebral
small vessel disease. The previous studies usually used ambulatory BP monitoring (ABPM).
However, recent data suggested that variability in BP on ABPM may be a weaker predictor of
vascular events than be visit-to-visit variability in clinic BP.
The investigators sought to find whether high visit-to-visit variability in clinic BP is
related with poor cognitive function in patients with cerebral small vessel disease.
This is a retrospective cohort study.
We include patients with cerebral small vessel disease, documented on MRI from Jan 2006 to
Dec 2010, who have been regularly followed up.
We evaluate the patients' cognitive function after written informed consent.
We independently review patients' medical record and analyze MRI data. BP variability
parameters include standard deviation(SD, primary measuring parameter), coefficient of
variation, successive variation, average real variability (ARV), SD independent of
mean(SDIM), SV independent of mean(SVIM), and ARV independent of mean (ARVIM). We will
adjust following confounding variables: age, sex, level of education, vascular risk factors,
mean SBP and DBP, NIHSS score, and white matter lesion burden on T2-weighted MRI.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04041349 -
Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
|
Phase 4 | |
Recruiting |
NCT04109963 -
Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment
|
Phase 2 | |
Not yet recruiting |
NCT06416371 -
Retinal Vessel Leakage in Cerebral Small Vessel Disease
|
||
Not yet recruiting |
NCT05967728 -
Testing of a System for Remote Ischemic Conditioning in Cerebral Small Vessel Disease and Pre-hospital Stroke Care
|
Phase 2 | |
Completed |
NCT05714813 -
Circuit Training and Retina
|
N/A | |
Not yet recruiting |
NCT06077305 -
A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke
|
||
Not yet recruiting |
NCT06061692 -
Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD)
|
Phase 4 | |
Recruiting |
NCT04962295 -
China Imaging-based Biobank of Cerebral Small Vessal Diseases
|
||
Completed |
NCT02801032 -
Effect of Tadalafil on Cerebral Large Arteries in Stroke
|
Phase 2 | |
Not yet recruiting |
NCT05594966 -
Neuroimaging Combining Biomarkers for Identifying Long-term Cognitive Dysfunction and Delirium
|
||
Terminated |
NCT02890888 -
Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease
|
N/A | |
Recruiting |
NCT04318119 -
Cerebral Small Vessel Disease Registry Study
|
||
Recruiting |
NCT03906123 -
The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia
|
N/A | |
Recruiting |
NCT05306834 -
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
|
N/A | |
Not yet recruiting |
NCT05583266 -
Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM)
|
Phase 4 | |
Recruiting |
NCT05173896 -
Improving Cerebral Blood Flow and Cognition in Patients With Cerebral Small Vessel Disease. The ETLAS-2 Trial
|
Phase 2 | |
Recruiting |
NCT01819441 -
Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
|
Phase 4 | |
Recruiting |
NCT04330222 -
Cambridge 7 Tesla Cerebral Small Vessel Disease Study
|
||
Recruiting |
NCT04298866 -
White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI
|
N/A | |
Not yet recruiting |
NCT06301711 -
Investigation of Potential Mechanisms in Stellate Ganglion Block in Individuals With Cerebral Small Vessel Disease
|
N/A |